JG
NVO

Jain Global’s Novo Nordisk NVO Stock Holding History

Jain Global’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$657K Sell
17,890
-201,039
-92% -$9.53M ﹤0.01% 892
2025
Q4 		$11.1M Buy
218,929
+110,692
+102% +$5.66M 0.05% 313
2025
Q3 		$6.01M Buy
108,237
+87,483
+422% +$5.12M 0.03% 322
2025
Q2 		$1.43M Buy
20,754
+6,576
+46% +$447K 0.01% 570
2025
Q1 		$985K Buy
+14,178
New +$1.17M 0.01% 442

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Jain Global's NVO Position: Q1 2026 in Review

Jain Global reduced its Novo Nordisk (NVO) stake by 92% in Q1 2026, selling an estimated $9.53M and leaving 17,890 shares worth $657K. The position accounts for ﹤0.01% of the portfolio, ranked #892.

Jain Global first reported a position in NVO in Q1 2025 and has held it in 5 quarters since. The position peaked at $11.1M in Q4 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Jain Global held 17,890 shares of Novo Nordisk worth $657K as of Q1 2026.
  • Jain Global sold 201,039 Novo Nordisk shares in Q1 2026, an estimated $9.53M.
  • Novo Nordisk made up ﹤0.01% of Jain Global's portfolio in Q1 2026, its #892 holding.
  • Jain Global first reported a position in Novo Nordisk in Q1 2025 and has held it in 5 quarters since.
  • Jain Global's Novo Nordisk position peaked at $11.1M in Q4 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.